{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T22:49:51Z","timestamp":1782168591094,"version":"3.54.5"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"26","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,7,14]]},"DOI":"10.1038\/s41388-026-03831-8","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T11:23:06Z","timestamp":1780312986000},"page":"2626-2642","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TIA1 depletion enhances CLSTN1 exon 11 inclusion to facilitate Epithelial-to-Mesenchymal transition and breast cancer metastasis"],"prefix":"10.1038","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5347-2195","authenticated-orcid":false,"given":"Yaxuan","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3420-2016","authenticated-orcid":false,"given":"Rongrong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8546-7119","authenticated-orcid":false,"given":"Xun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3954-7529","authenticated-orcid":false,"given":"Wuqin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8032-9360","authenticated-orcid":false,"given":"Huimin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiezong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongping","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3483-2847","authenticated-orcid":false,"given":"Xiaohui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"3831_CR1","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/0092-8674(80)90617-0","volume":"20","author":"P Early","year":"1980","unstructured":"Early P, Rogers J, Davis M, Calame K, Bond M, Wall R, et al. Two mRNAs can be produced from a single immunoglobulin mu gene by alternative RNA processing pathways. Cell. 1980;20:313\u20139.","journal-title":"Cell"},{"key":"3831_CR2","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nature08909","volume":"463","author":"TW Nilsen","year":"2010","unstructured":"Nilsen TW, Graveley BR. Expansion of the eukaryotic proteome by alternative splicing. Nature. 2010;463:457\u201363.","journal-title":"Nature"},{"key":"3831_CR3","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/s41588-021-00851-w","volume":"53","author":"PV Mazin","year":"2021","unstructured":"Mazin PV, Khaitovich P, Cardoso-Moreira M, Kaessmann H. Alternative splicing during mammalian organ development. Nat Genet. 2021;53:925\u2013934.","journal-title":"Nat Genet"},{"key":"3831_CR4","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/imr.12047","volume":"253","author":"NM Martinez","year":"2013","unstructured":"Martinez NM, Lynch KW. Control of alternative splicing in immune responses: many regulators, many predictions, much still to learn. Immunol Rev. 2013;253:216\u201336.","journal-title":"Immunol Rev"},{"key":"3831_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/nature09000","volume":"465","author":"Y Barash","year":"2010","unstructured":"Barash Y, Calarco JA, Gao W, Pan Q, Wang X, Shai O, et al. Deciphering the splicing code. Nature. 2010;465:53\u20139.","journal-title":"Nature"},{"key":"3831_CR6","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/nature07509","volume":"456","author":"ET Wang","year":"2008","unstructured":"Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, et al. Alternative isoform regulation in human tissue transcriptomes. Nature. 2008;456:470\u20136.","journal-title":"Nature"},{"key":"3831_CR7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41568-022-00541-7","volume":"23","author":"RK Bradley","year":"2023","unstructured":"Bradley RK, Anczuk\u00f3w O. RNA splicing dysregulation and the hallmarks of cancer. Nat Rev Cancer. 2023;23:135\u2013155.","journal-title":"Nat Rev Cancer"},{"key":"3831_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1532","volume":"10","author":"S Nik","year":"2019","unstructured":"Nik S, Bowman TV. Splicing and neurodegeneration: Insights and mechanisms. Wiley Interdiscip Rev RNA. 2019;10:e1532.","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"3831_CR9","doi-asserted-by":"crossref","unstructured":"Sun Y, Hu X. Aberrant alternative splicing in cancer: Splicing events and their regulatory mechanisms (Review). Int J Oncol. 2024;65:90.","DOI":"10.3892\/ijo.2024.5678"},{"key":"3831_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000147748","volume":"154","author":"ED Hay","year":"1995","unstructured":"Hay ED. An overview of epithelio-mesenchymal transformation. Acta Anat (Basel). 1995;154:8\u201320.","journal-title":"Acta Anat (Basel)"},{"key":"3831_CR11","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","volume":"168","author":"AW Lambert","year":"2017","unstructured":"Lambert AW, Pattabiraman DR, Weinberg RA. Emerging biological principles of metastasis. Cell. 2017;168:670\u2013691.","journal-title":"Cell"},{"key":"3831_CR12","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nrc822","volume":"2","author":"JP Thiery","year":"2002","unstructured":"Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002;2:442\u201354.","journal-title":"Nat Rev Cancer"},{"key":"3831_CR13","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178\u201396.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3831_CR14","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/35000025","volume":"2","author":"A Cano","year":"2000","unstructured":"Cano A, P\u00e9rez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol. 2000;2:76\u201383.","journal-title":"Nat Cell Biol"},{"key":"3831_CR15","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.cell.2004.06.006","volume":"117","author":"J Yang","year":"2004","unstructured":"Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 2004;117:927\u201339.","journal-title":"Cell"},{"key":"3831_CR16","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1038\/sj.onc.1208429","volume":"24","author":"A Eger","year":"2005","unstructured":"Eger A, Aigner K, Sonderegger S, Dampier B, Oehler S, Schreiber M, et al. DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene. 2005;24:2375\u201385.","journal-title":"Oncogene"},{"key":"3831_CR17","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S1097-2765(01)00260-X","volume":"7","author":"J Comijn","year":"2001","unstructured":"Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E, et al. The two-handed E-box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell. 2001;7:1267\u201378.","journal-title":"Mol Cell"},{"key":"3831_CR18","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1172\/JCI44540","volume":"121","author":"RL Brown","year":"2011","unstructured":"Brown RL, Reinke LM, Damerow MS, Perez D, Chodosh LA, Yang J, et al. CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression. J Clin Invest. 2011;121:1064\u201374.","journal-title":"J Clin Invest"},{"key":"3831_CR19","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1101\/gad.319889.118","volume":"33","author":"H Zhang","year":"2019","unstructured":"Zhang H, Brown RL, Wei Y, Zhao P, Liu S, Liu X, et al. CD44 splice isoform switching determines breast cancer stem cell state. Genes Dev. 2019;33:166\u2013179.","journal-title":"Genes Dev"},{"key":"3831_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.tcb.2010.10.001","volume":"21","author":"F Gertler","year":"2011","unstructured":"Gertler F, Condeelis J. Metastasis: tumor cells becoming MENAcing. Trends Cell Biol. 2011;21:81\u201390.","journal-title":"Trends Cell Biol"},{"key":"3831_CR21","doi-asserted-by":"publisher","first-page":"335","DOI":"10.5483\/BMBRep.2021.54.7.048","volume":"54","author":"HY Choi","year":"2021","unstructured":"Choi HY, Seok J, Kang GH, Lim KM, Cho SG. The role of NUMB\/NUMB isoforms in cancer stem cells. BMB Rep. 2021;54:335\u2013343.","journal-title":"BMB Rep"},{"key":"3831_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1749-8104-5-31","volume":"5","author":"A Karaczyn","year":"2010","unstructured":"Karaczyn A, Bani-Yaghoub M, Tremblay R, Kubu C, Cowling R, Adams TL, et al. Two novel human NUMB isoforms provide a potential link between development and cancer. Neural Dev. 2010;5:31.","journal-title":"Neural Dev"},{"key":"3831_CR23","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1006\/dbio.1993.1205","volume":"158","author":"A Orr-Urtreger","year":"1993","unstructured":"Orr-Urtreger A, Bedford MT, Burakova T, Arman E, Zimmer Y, Yayon A, et al. Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2). Dev Biol. 1993;158:475\u201386.","journal-title":"Dev Biol"},{"key":"3831_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-020-00582-1","volume":"18","author":"D Ranieri","year":"2020","unstructured":"Ranieri D, Nanni M, Persechino F, Torrisi MR, Belleudi F. Role of PKC\u03b5 in the epithelial-mesenchymal transition induced by FGFR2 isoform switch. Cell Commun Signal. 2020;18:76.","journal-title":"Cell Commun Signal"},{"key":"3831_CR25","doi-asserted-by":"publisher","first-page":"36435","DOI":"10.1074\/jbc.M112.397125","volume":"287","author":"LM Reinke","year":"2012","unstructured":"Reinke LM, Xu Y, Cheng C. Snail represses the splicing regulator epithelial splicing regulatory protein 1 to promote epithelial-mesenchymal transition. J Biol Chem. 2012;287:36435\u201342.","journal-title":"J Biol Chem"},{"key":"3831_CR26","doi-asserted-by":"publisher","first-page":"546","DOI":"10.4161\/rna.6.5.9606","volume":"6","author":"CC Warzecha","year":"2009","unstructured":"Warzecha CC, Shen S, Xing Y, Carstens RP. The epithelial splicing factors ESRP1 and ESRP2 positively and negatively regulate diverse types of alternative splicing events. RNA Biol. 2009;6:546\u201362.","journal-title":"RNA Biol"},{"key":"3831_CR27","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/nsmb.2699","volume":"20","author":"MT Lovci","year":"2013","unstructured":"Lovci MT, Ghanem D, Marr H, Arnold J, Gee S, Parra M, et al. Rbfox proteins regulate alternative mRNA splicing through evolutionarily conserved RNA bridges. Nat Struct Mol Biol. 2013;20:1434\u201342.","journal-title":"Nat Struct Mol Biol"},{"key":"3831_CR28","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1101\/gad.241968.114","volume":"28","author":"Y Xu","year":"2014","unstructured":"Xu Y, Gao XD, Lee JH, Huang H, Tan H, Ahn J, et al. Cell type-restricted activity of hnRNPM promotes breast cancer metastasis via regulating alternative splicing. Genes Dev. 2014;28:1191\u2013203.","journal-title":"Genes Dev"},{"key":"3831_CR29","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1261\/rna.066712.118","volume":"24","author":"SE Harvey","year":"2018","unstructured":"Harvey SE, Xu Y, Lin X, Gao XD, Qiu Y, Ahn J, et al. Coregulation of alternative splicing by hnRNPM and ESRP1 during EMT. Rna. 2018;24:1326\u20131338.","journal-title":"Rna"},{"key":"3831_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.105742","volume":"300","author":"T Iwata","year":"2024","unstructured":"Iwata T, Kishikawa T, Seimiya T, Notoya G, Suzuki T, Shibata C, et al. Satellite double-stranded RNA induces mesenchymal transition in pancreatic cancer by regulating alternative splicing. J Biol Chem. 2024;300:105742.","journal-title":"J Biol Chem"},{"key":"3831_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14304-1","volume":"11","author":"X Hu","year":"2020","unstructured":"Hu X, Harvey SE, Zheng R, Lyu J, Grzeskowiak CL, Powell E, et al. The RNA-binding protein AKAP8 suppresses tumor metastasis by antagonizing EMT-associated alternative splicing. Nat Commun. 2020;11:486.","journal-title":"Nat Commun"},{"key":"3831_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-018-0309-z","volume":"16","author":"JY He","year":"2018","unstructured":"He JY, Wei XH, Li SJ, Liu Y, Hu HL, Li ZZ, et al. Adipocyte-derived IL-6 and leptin promote breast Cancer metastasis via upregulation of Lysyl Hydroxylase-2 expression. Cell Commun Signal. 2018;16:100.","journal-title":"Cell Commun Signal"},{"key":"3831_CR33","doi-asserted-by":"crossref","unstructured":"Berens EB, Holy JM, Riegel AT, Wellstein A. A cancer cell spheroid assay to assess invasion in a 3D setting. J Vis Exp. 2015;105:e53409.","DOI":"10.3791\/53409-v"},{"key":"3831_CR34","doi-asserted-by":"crossref","unstructured":"Das DK, Naidoo MK, Ilboudo A, DuBois P, Durojaiye V, Liu C, et al. Isolation and propagation of circulating tumor cells from a mouse cancer model. J Vis Exp. 2015;104:e52861.","DOI":"10.3791\/52861"},{"key":"3831_CR35","doi-asserted-by":"crossref","unstructured":"Sun Y, Zhou X, Hu X. Constructing a doxycycline-inducible system for an epithelial-to-mesenchymal transition model in MCF10A cells. Biol Open. 2024;13:bio061790.","DOI":"10.1242\/bio.061790"},{"key":"3831_CR36","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1126\/science.1228522","volume":"339","author":"M Yu","year":"2013","unstructured":"Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT, et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science. 2013;339:580\u20134.","journal-title":"Science"},{"key":"3831_CR37","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1007\/s10555-024-10198-3","volume":"43","author":"Y Qiu","year":"2024","unstructured":"Qiu Y, Gao T, Smith BR. Mechanical deformation and death of circulating tumor cells in the bloodstream. Cancer Metastasis Rev. 2024;43:1489\u20131510.","journal-title":"Cancer Metastasis Rev"},{"key":"3831_CR38","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/ajcp\/73.3.313","volume":"73","author":"ER Fisher","year":"1980","unstructured":"Fisher ER, Palekar AS, Redmond C, Barton B, Fisher B. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4). VI. Invasive papillary cancer. Am J Clin Pathol. 1980;73:313\u201322.","journal-title":"Am J Clin Pathol"},{"key":"3831_CR39","doi-asserted-by":"publisher","first-page":"58","DOI":"10.2325\/jbcs.13.58","volume":"13","author":"YS Li","year":"2006","unstructured":"Li YS, Kaneko M, Sakamoto DG, Takeshima Y, Inai K. The reversed apical pattern of MUC1 expression is characteristics of invasive micropapillary carcinoma of the breast. Breast Cancer. 2006;13:58\u201363.","journal-title":"Breast Cancer"},{"key":"3831_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27794-4","volume":"13","author":"Q Shi","year":"2022","unstructured":"Shi Q, Shao K, Jia H, Cao B, Li W, Dong S, et al. Genomic alterations and evolution of cell clusters in metastatic invasive micropapillary carcinoma of the breast. Nat Commun. 2022;13:111.","journal-title":"Nat Commun"},{"key":"3831_CR41","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10549-024-07384-w","volume":"208","author":"O Oz","year":"2024","unstructured":"Oz O, Irmak Yuzuguldu R, Yazici A, Kocatepe Cavdar D, Yilmaz C, Ozturk M, et al. The differences between pure and mixed invasive micropapillary breast cancer: the epithelial-mesenchymal transition molecules and prognosis. Breast Cancer Res Treat. 2024;208:41\u201355.","journal-title":"Breast Cancer Res Treat"},{"key":"3831_CR42","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/2350073","volume":"2024","author":"O Oz","year":"2024","unstructured":"Oz O, Tasli FA, Yuzuguldu RI, Zengel B, Cavdar DK, Durak MG, et al. Comprehensive immunohistochemical analysis of epithelial-mesenchymal transition biomarkers in the invasive micropapillary cancer of the breast. Int J Breast Cancer. 2024;2024:2350073.","journal-title":"Int J Breast Cancer"},{"key":"3831_CR43","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10549-005-7727-5","volume":"94","author":"C Nagi","year":"2005","unstructured":"Nagi C, Guttman M, Jaffer S, Qiao R, Keren R, Triana A, et al. N-cadherin expression in breast cancer: correlation with an aggressive histologic variant-invasive micropapillary carcinoma. Breast Cancer Res Treat. 2005;94:225\u201335.","journal-title":"Breast Cancer Res Treat"},{"key":"3831_CR44","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/s42003-024-06121-9","volume":"7","author":"V Baylot","year":"2024","unstructured":"Baylot V, Le TK, Ta\u00efeb D, Rocchi P, Colleaux L. Between hope and reality: treatment of genetic diseases through nucleic acid-based drugs. Commun Biol. 2024;7:489.","journal-title":"Commun Biol"},{"key":"3831_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-020-07291-6","volume":"21","author":"X Pan","year":"2020","unstructured":"Pan X, Fang Y, Li X, Yang Y, Shen HB. RBPsuite: RNA-protein binding sites prediction suite based on deep learning. BMC Genomics. 2020;21:884.","journal-title":"BMC Genomics"},{"key":"3831_CR46","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/nar\/gkq1069","volume":"39","author":"KB Cook","year":"2011","unstructured":"Cook KB, Kazan H, Zuberi K, Morris Q, Hughes TR. RBPDB: a database of RNA-binding specificities. Nucleic Acids Res. 2011;39:301\u20138.","journal-title":"Nucleic Acids Res"},{"key":"3831_CR47","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41392-024-01734-2","volume":"9","author":"Y Tao","year":"2024","unstructured":"Tao Y, Zhang Q, Wang H, Yang X, Mu H. Alternative splicing and related RNA binding proteins in human health and disease. Signal Transduct Target Ther. 2024;9:26.","journal-title":"Signal Transduct Target Ther"},{"key":"3831_CR48","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1006\/mcne.2000.0937","volume":"17","author":"L Vogt","year":"2001","unstructured":"Vogt L, Schrimpf SP, Meskenaite V, Frischknecht R, Kinter J, Leone DP, et al. Calsyntenin-1, a proteolytically processed postsynaptic membrane protein with a cytoplasmic calcium-binding domain. Mol Cell Neurosci. 2001;17:151\u201366.","journal-title":"Mol Cell Neurosci"},{"key":"3831_CR49","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fncel.2017.00107","volume":"11","author":"TJ Lee","year":"2017","unstructured":"Lee TJ, Lee JW, Haynes EM, Eliceiri KW, Halloran MC. The kinesin adaptor Calsyntenin-1 organizes microtubule polarity and regulates dynamics during sensory axon arbor development. Front Cell Neurosci. 2017;11:107.","journal-title":"Front Cell Neurosci"},{"key":"3831_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06507-x","volume":"15","author":"Z Dou","year":"2024","unstructured":"Dou Z, Lei H, Su W, Zhang T, Chen X, Yu B, et al. Modification of BCLX pre-mRNA splicing has antitumor efficacy alone or in combination with radiotherapy in human glioblastoma cells. Cell Death Dis. 2024;15:160.","journal-title":"Cell Death Dis"},{"key":"3831_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34042-w","volume":"13","author":"Z Wang","year":"2022","unstructured":"Wang Z, Wang S, Qin J, Zhang X, Lu G, Liu H, et al. Splicing factor BUD31 promotes ovarian cancer progression through sustaining the expression of anti-apoptotic BCL2L12. Nat Commun. 2022;13:6246.","journal-title":"Nat Commun"},{"key":"3831_CR52","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1172\/JCI82534","volume":"126","author":"M Dewaele","year":"2016","unstructured":"Dewaele M, Tabaglio T, Willekens K, Bezzi M, Teo SX, Low DH, et al. Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growth. J Clin Invest. 2016;126:68\u201384.","journal-title":"J Clin Invest"},{"key":"3831_CR53","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","volume":"19","author":"TC Roberts","year":"2020","unstructured":"Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020;19:673\u2013694.","journal-title":"Nat Rev Drug Discov"},{"key":"3831_CR54","doi-asserted-by":"publisher","first-page":"17181","DOI":"10.1074\/jbc.M311683200","volume":"279","author":"H Wu","year":"2004","unstructured":"Wu H, Lima WF, Zhang H, Fan A, Sun H, Crooke ST. Determination of the role of the human RNase H1 in the pharmacology of DNA-like antisense drugs. J Biol Chem. 2004;279:17181\u20139.","journal-title":"J Biol Chem"},{"key":"3831_CR55","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.ajhg.2008.01.014","volume":"82","author":"Y Hua","year":"2008","unstructured":"Hua Y, Vickers TA, Okunola HL, Bennett CF, Krainer AR. Antisense masking of an hnRNP A1\/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice. Am J Hum Genet. 2008;82:834\u201348.","journal-title":"Am J Hum Genet"},{"key":"3831_CR56","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41420-023-01757-8","volume":"9","author":"C Li","year":"2023","unstructured":"Li C, Yin Y, Tao R, Lin Y, Wang T, Shen Q, et al. ESRP1-driven alternative splicing of CLSTN1 inhibits the metastasis of gastric cancer. Cell Death Discov. 2023;9:464.","journal-title":"Cell Death Discov"},{"key":"3831_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3480","volume":"4","author":"JP Venables","year":"2013","unstructured":"Venables JP, Lapasset L, Gadea G, Fort P, Klinck R, Irimia M, et al. MBNL1 and RBFOX2 cooperate to establish a splicing programme involved in pluripotent stem cell differentiation. Nat Commun. 2013;4:2480.","journal-title":"Nat Commun"},{"key":"3831_CR58","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/0092-8674(91)90536-8","volume":"67","author":"Q Tian","year":"1991","unstructured":"Tian Q, Streuli M, Saito H, Schlossman SF, Anderson P. A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells. Cell. 1991;67:629\u201339.","journal-title":"Cell"},{"key":"3831_CR59","doi-asserted-by":"publisher","first-page":"8665","DOI":"10.1093\/nar\/gkt579","volume":"41","author":"S Bonomi","year":"2013","unstructured":"Bonomi S, di Matteo A, Buratti E, Cabianca DS, Baralle FE, Ghigna C, et al. HnRNP A1 controls a splicing regulatory circuit promoting mesenchymal-to-epithelial transition. Nucleic Acids Res. 2013;41:8665\u201379.","journal-title":"Nucleic Acids Res"},{"key":"3831_CR60","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1101\/gad.305862.117","volume":"31","author":"H Huang","year":"2017","unstructured":"Huang H, Zhang J, Harvey SE, Hu X, Cheng C. RNA G-quadruplex secondary structure promotes alternative splicing via the RNA-binding protein hnRNPF. Genes Dev. 2017;31:2296\u20132309.","journal-title":"Genes Dev"},{"key":"3831_CR61","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/j.1742-4658.2010.07992.x","volume":"278","author":"G Ghosh","year":"2011","unstructured":"Ghosh G, Adams JA. Phosphorylation mechanism and structure of serine-arginine protein kinases. FEBS J 2011;278:587\u201397.","journal-title":"FEBS J"},{"key":"3831_CR62","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41590-021-00896-3","volume":"22","author":"M Takahashi","year":"2021","unstructured":"Takahashi M, Lio CJ, Campeau A, Steger M, Ay F, Mann M, et al. The tumor suppressor kinase DAPK3 drives tumor-intrinsic immunity through the STING-IFN-\u03b2 pathway. Nat Immunol. 2021;22:485\u2013496.","journal-title":"Nat Immunol"},{"key":"3831_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.102831","volume":"24","author":"HM Chen","year":"2021","unstructured":"Chen HM, MacDonald JA. Network analysis identifies DAPK3 as a potential biomarker for lymphatic invasion and colon adenocarcinoma prognosis. iScience. 2021;24:102831.","journal-title":"iScience"},{"key":"3831_CR64","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/pnasnexus\/pgae401","volume":"3","author":"J Wang","year":"2024","unstructured":"Wang J, Tran-Huynh AM, Kim BJ, Chan DW, Holt MV, Fandino D, et al. Death-associated protein kinase 3 modulates migration and invasion of triple-negative breast cancer cells. PNAS Nexus. 2024;3:401.","journal-title":"PNAS Nexus"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03831-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03831-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03831-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T22:02:24Z","timestamp":1782165744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03831-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":64,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2026,7,14]]}},"alternative-id":["3831"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03831-8","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. All animal procedures were approved by the Institutional Animal Care and Use Committee at Anhui Medical University (No. 20210951). The use of patient samples was approved by the Institutional Review Board of Anhui Medical University (No. 20210587). Informed consent was obtained from all participants. No identifiable images were used.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}